Proxalutamide Treatment for COVID-19 Female Outpatients
NCT04853134
·
clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
This study was combined with another study
Conditions
Covid19
SARS-CoV Infection
Interventions
DRUG:
Proxalutamide
OTHER:
Standard of Care
Sponsor
Applied Biology, Inc.